Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly Exchange Rate Effect came in at -$7000.0 in Q1 2026, down 121.88% year-on-year from $32000.0 in Q1 2025, and down 163.64% on a QoQ basis from $11000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Exchange Rate Effect data on file, last reported at -$7000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 121.88% year-over-year to -$7000.0 in Q1 2026; TTM through Mar 2026 was $6000.0, a 62.5% decrease from a year earlier, with the FY2025 full-year figure at $45000.0, up 314.29% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$7000.0, down from $11000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for RNAC reached as high as $115000.0 in Q2 2022 and fell as low as -$45000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$941.18 across 5 years, with a median of -$10000.0 in 2025.
- Across the five-year window, Exchange Rate Effect slumped 650.0% in 2022 and soared 740.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$45000.0 in 2022, then jumped by 135.56% to $16000.0 in 2023, then tumbled by 193.75% to -$15000.0 in 2024, then jumped by 173.33% to $11000.0 in 2025, then sank by 163.64% to -$7000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$7000.0 in Q1 2026, $11000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cartesian Therapeutics | 226.07 Mn | 226.07 Mn | - | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |